Clinical application of
- Conditions
- COVID-19
- Registration Number
- ITMCTR2200006066
- Lead Sponsor
- Shanghai Tenth People's Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
1.18= age =80 years old, no gender limitation;
2.Meet the diagnostic criteria for mild and common cases in COVID-19 Diagnosis and Treatment Protocol (Trial Version 9) released by the National Health Commission ;
3.Voluntarily participate in the case registration study and sign the informed consent.
1. Severe and critically ill COVID-19 patients;
2. Any other chronic respiratory diseases, respiratory bacterial infections such as suppurative tonsillitis, acute trachea-bronchitis, sinusitis, otitis media and other respiratory diseases with impact assessment;
3. Patients with serious pulmonary interstitial disease, bronchiectasis, primary immune deficiency disease, congenital respiratory malformation, congenital heart disease, abnormal lung development and other basic diseases;
4. Patients with severe liver disease [ASpartate aminotransferase (AST), alanine aminotransferase (ALT) exceeding 5 times the normal upper limit], or with severe renal insufficiency or undergoing continuous renal replacement therapy, hemodialysis, or peritoneal dialysis;
5. Malignant tumors with multiple metastases that cannot be resected, hematologic diseases, malignant fluid, active bleeding, severe malnutrition, HIV, or severe neurological or psychiatric diseases;
6. Unwilling to cooperate with TCM syndrome differentiation to treat patients.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ucleic acid turning negative time;
- Secondary Outcome Measures
Name Time Method Symptom relief rate;ransfer rate of severe;Hospitalization days;7 days nucleic acid detection Ct value up to standard rate;Cytokines and lymphocyte subsets;